Loading...
Systolic blood pressure, cardiovascular outcomes and efficacy and safety of sacubitril/valsartan (LCZ696) in patients with chronic heart failure and reduced ejection fraction: results from PARADIGM-HF
BACKGROUND: Compared to heart failure patients with higher systolic blood pressure (SBP), those with lower SBP have a worse prognosis. To make matters worse, the latter patients often do not receive treatment with life-saving therapies that might lower blood pressure further. We examined the associa...
Na minha lista:
| Udgivet i: | Eur Heart J |
|---|---|
| Main Authors: | , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Oxford University Press
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6251522/ https://ncbi.nlm.nih.gov/pubmed/28158398 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/eurheartj/ehw570 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|